U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
RUPLIZUMAB
INN   USAN  
INN   USAN  
Official Name English
BG-9588
Preferred Name English
Ruplizumab [WHO-DD]
Common Name English
ruplizumab [INN]
Common Name English
BG9588
Code English
HU5C8
Code English
HU-5C8
Code English
RUPLIZUMAB [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 123499
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
FDA ORPHAN DRUG 109897
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
FDA ORPHAN DRUG 120098
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
FDA ORPHAN DRUG 113798
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
NCI_THESAURUS C574
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
FDA ORPHAN DRUG 111298
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
Code System Code Type Description
INN
8014
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
SMS_ID
300000021908
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
NCI_THESAURUS
C152273
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108767
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
DRUG BANK
DB06475
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
USAN
KK-92
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
WIKIPEDIA
Ruplizumab
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
CAS
220651-94-5
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
FDA UNII
562JQF15GN
Created by admin on Mon Mar 31 23:29:39 GMT 2025 , Edited by admin on Mon Mar 31 23:29:39 GMT 2025
PRIMARY
ACTIVE MOIETY
RUPLIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966